Aligos Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$4.00 | -$4.00 | -$4.00 |
| Q2 2024 | 1 | -$2.16 | -$2.16 | -$2.16 |
| Q3 2024 | 2 | -$3.67 | -$1.83 | -$2.50 |
| Q1 2025 | 2 | -$4.23 | -$1.85 | -$2.76 |
| Q2 2025 | 1 | -$2.97 | -$2.97 | -$2.97 |
| Q3 2025 | 1 | -$3.06 | -$3.06 | -$3.06 |
| Q4 2025 | 1 | -$3.10 | -$3.10 | -$3.10 |
Aligos Therapeutics, Inc. Earnings Date And Information
Aligos Therapeutics, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-3.07 earnings per share for the quarter, missing analysts' consensus estimates of $-2.15 by $0.92. The company had revenue of 1.27 M for the quarter and had revenue of 15.53 M for the year. Aligos Therapeutics, Inc. has generated $-4 earnings per share over the last year ($-3.52 diluted earnings per share) and currently has a price-to-earnings ratio of -1.51. Aligos Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Aligos Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$2.15 | -$3.07 | -0.92 | $333,333 | $1.27 M |
| 08/06/2024 | Q2 2024 | -$4.00 | $0.81 | 4.81 | $1.06 M | $1.06 M |
| 05/07/2024 | Q1 2024 | -$0.19 | -$5.58 | -5.39 | $986,000 | |
| 03/12/2024 | Q4 2023 | -$0.27 | -$1.12 | -0.85 | $2.68 M | |
| 11/02/2023 | Q3 2023 | -$0.48 | -$0.41 | 0.07 | $2.50 M | $3.24 M |
| 08/03/2023 | Q2 2023 | -$0.50 | -$0.43 | 0.07 | $6.89 M | |
| 05/04/2023 | Q1 2023 | -$0.49 | -$0.53 | -0.04 | $2.72 M | |
| 03/09/2023 | Q4 2022 | -$0.49 | -$0.51 | -0.02 | $3.54 M | |
| 11/02/2022 | Q3 2022 | -$0.57 | -$0.44 | 0.13 | $750,000 | $4.11 M |
| 08/04/2022 | Q2 2022 | -$0.65 | -$0.47 | 0.18 | $3.69 M | |
| 05/04/2022 | Q1 2022 | -$0.66 | -$0.84 | -0.18 | $2.57 M | |
| 03/10/2022 | Q4 2021 | -$0.83 | -$0.89 | -0.06 | $367,000 | |
| 11/04/2021 | Q3 2021 | -$0.83 | -$0.78 | 0.05 | $1.54 M | |
| 08/05/2021 | Q2 2021 | -$0.81 | -$0.79 | 0.02 | $1.55 M | |
| 05/10/2021 | Q1 2021 | -$0.90 | -$0.74 | 0.16 | $910,000 | |
| 03/23/2021 | Q4 2020 | -$0.82 | -$1.09 | -0.27 | $0 | |
| 11/25/2020 | Q3 2020 | -$0.78 | -$0.90 | -0.12 | $2.03 M | |
| 06/29/2020 | Q2 2020 | -$0.95 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.91 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.83 | $0 |
Aligos Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Aligos Therapeutics, Inc.'s earnings date?
Aligos Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
-
How can I listen to Aligos Therapeutics, Inc.'s earnings conference call?
The conference call for Aligos Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Aligos Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Aligos Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Aligos Therapeutics, Inc. generate each year?
Aligos Therapeutics, Inc. (:ALGS) has a recorded annual revenue of $15.53 M.
-
How much profit does Aligos Therapeutics, Inc. generate each year?
Aligos Therapeutics, Inc. (:ALGS) has a recorded net income of $15.53 M. Aligos Therapeutics, Inc. has generated $-3.52 earnings per share over the last four quarters.
-
What is Aligos Therapeutics, Inc.'s price-to-earnings ratio?
Aligos Therapeutics, Inc. (:ALGS) has a price-to-earnings ratio of -1.51 and price/earnings-to-growth ratio is -0.2.
